CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Fabio Arturo Iannotti

OPENALEX: A5036558609↗ORCID: 0000-0003-4480-8370↗

Affiliations

Organizations

Istituto di Chimica Biomolecolareauthorship · IT National Research Councilauthorship · IT

Public evidence

5 connected articles

Cannabidiol attenuates epileptic phenotype and increases survival in a mouse model of developmental and epileptic encephalopathy type 1.2025 · Europe PMC Dysfunctional endocannabinoid CB1 receptor expression and signaling contribute to skeletal muscle cell toxicity induced by simvastatin.2023 · Europe PMC The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets.2021 · Europe PMC Beneficial Effects of <i>Akkermansia muciniphila</i> Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists.2021 · Europe PMC Identification and Characterization of Cannabimovone, a Cannabinoid from <i>Cannabis sativa</i>, as a Novel PPARγ Agonist via a Combined Computational and Functional Study.2020 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Fabio Arturo Iannotti - Medical Cannabis Research Engine